Amicus Therapeutics, Inc. (FOLD) Tops Q4 EPS by 12c
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Price: $14.49 --0%
Financial Fact:
Interest expense: -1.52M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Interest expense: -1.52M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Amicus Therapeutics, Inc. (NASDAQ: FOLD) reported Q4 EPS of ($0.25), $0.12 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $922 thousand, versus the consensus estimate of $6.06 million.
For earnings history and earnings-related data on Amicus Therapeutics, Inc. (FOLD) click here.
For earnings history and earnings-related data on Amicus Therapeutics, Inc. (FOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Morgan Stanley upgrades Synopsys as it turns selective on chip stocks
- Metavesco's Epic Labor Reports $382,730 in August 2026 Revenue, Up Approximately 129% Year-Over-Year
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
